Clinical Trial

Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn more about how stimulating the nerves involved in sensation (either in the limbs or in the brain) can be used to restore sensation in participants who have a spinal cord injury. Participants in this study will have already been enrolled in the "Reconnecting the Hand and Arm to the Brain (ReHAB)" study, and received small electrodes in a part of the brain that is involved in sensing touch and pressure in the hand. The ReHAB study participants will also have received electrodes around the nerves in their arm. In this clinical trial, participants will receive two types of electrical stimulation: * Intracortical microstimulation (ICMS) which involves sending small electrical pulses to the part of the brain that processes sensation. * Peripheral nerve stimulation (PNS) which involves sending small electrical pulses to the nerves in the arm that transmit sensations from the hand. Researchers will try different patterns of stimulation for both ICMS and PNS and study how the participants perceive the sensations from the different stimulation patterns. The researchers will also study how combining ICMS and PNS affects the perceived sensations.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-05; most recent amendment 2026-02-17.
Status change: Not Yet Recruiting → Recruiting 2025-12-03
Trial Details
NCT Number NCT07225582
Lead Sponsor Case Western Reserve University
Collaborators: University Hospitals Cleveland Medical Center, Cleveland Clinic Lerner Research Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Spinal Cord Injury Cervical, Spinal Cord Injuries (Complete and Incomplete)
Enrollment 3 participants
Start Date 2026-01-13
Primary Completion 2030-09-01 (estimated)
Study Completion 2030-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-19